Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Molecular Oncology|April 22, 2014
PDGFRβ and FGFR2 mediate endothelial cell differentiation capability of triple negative breast carcinoma cellsIlaria Plantamura, Patrizia Casalini, Erica Dugnani, et al.
Oncogene|February 2, 2019
WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancerLorenzo Castagnoli, Valeria Cancila, Sandra L Cordoba-Romero, et al.
Frontiers in Oncology|February 17, 2023
End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTOSerena Di Cosimo, Chiara M Ciniselli, Sara Pizzamiglio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2019
Plasma miRNA Levels for Predicting Therapeutic Response to Neoadjuvant Treatment in HER2-positive Breast Cancer: Results from the NeoALTTO TrialSerena Di Cosimo, Valentina Appierto, Sara Pizzamiglio, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 17, 2005
miR-15 and miR-16 induce apoptosis by targeting BCL2Amelia Cimmino, George Adrian Calin, Muller Fabbri, et al.
Cancer Research|August 17, 2005
MicroRNA gene expression deregulation in human breast cancerMarilena V Iorio, Manuela Ferracin, Chang-Gong Liu, et al.
Cancer Medicine|December 18, 2021
What if the future of HER2-positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO studySara Pizzamiglio, Giulia Cosentino, Chiara M Ciniselli, et al.
Molecular Oncology|January 17, 2019
Expression of long non-coding RNA ENSG00000226738 (LncKLHDC7B) is enriched in the immunomodulatory triple-negative breast cancer subtype and its alteration promotes cell migration, invasion, and resistance to cell deathFredy Omar Beltrán-Anaya, Sandra Romero-Córdoba, Rosa Rebollar-Vega, et al.
Plos Genetics|March 19, 2013
Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor statusGianpiero Di Leva, Claudia Piovan, Pierluigi Gasparini, et al.
The New England Journal of Medicine|October 28, 2005
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemiaGeorge Adrian Calin, Manuela Ferracin, Amelia Cimmino, et al.
Pageof 6